Growing Incidences Of Cardiovascular And Neurodegenerative Disorders Is Expected To Drive The Global Apoptosis Market

According to a recently published report, the global Apoptosis Market is expected to grow at a significant rate during 2016-2022. The global apoptosis market is segmented on the basis of therapies, indications, drug class and consumables and, geography. The report on global apoptosis market forecast, 2016-2022 (by therapies, indications, drug class and consumables and geography) provides detailed overview and predictive analysis of the market.

Full report available global apoptosis market forecast, 2016-2022 (therapies, indications, drug class and consumables, and geography) report at

Apoptosis is the programmed process of cell death which occurs from natural stimuli to eliminate unusual cell division, old cells, unhealthy and unnecessary cells in the body. Growing incidences of cardiovascular and neurodegenerative disorders is the major driver for the global apoptosis market. Incidences of cardiovascular and neurodegenerative disorders are increasing year by year, which in turn increases the growth rate of global apoptosis market. Cardiovascular disorder includes abnormal heart rhythms (arrhythmias), congenital heart disease, coronary artery disease, cardiomyopathy or heart muscle disease, heart valve disease, heart attack, pericardial disease and many more. These cardiovascular disorders are the major cause of death. Whereas, neurodegenerative (group of brain diseases) disorder includes parkinson's, amyotrophic lateral sclerosis, huntington's , alzheimer’s, degenerative nerve diseases, genetic brain disorders, prion diseases, multiple sclerosis and many more, which are caused due to several factors such as overstimulation of nerve cells, unhealthy lifestyle and oxidative stress caused by toxins, and is related with atrophy of the affected peripheral or central structures of the nervous system and it can be found in various different levels of neuronal circuitry which ranges from molecular to systemic.

Scope Of The Report

1. Global Apoptosis Market By Therapies 2012 - 2022 ($ Million)
1.1. Gene Based Therapy
1.2. Drug Based Therapy
1.3. Immune Based Therapy

2. Global Apoptosis Market By Indications 2012 - 2022 ($ Million)
2.1. Cancer
2.2. Cardiovascular
2.3. Neurodegenerative Diseases
2.4. Others

3. Global Apoptosis Market By Drug Class And Consumables 2012 - 2022 ($ Million)
3.1. Direct Apoptogens
3.2. First Generation Indirect Apoptogens
3.3. Second Generation Indirect Apoptogens
3.4. Reagents And Kits

4. Global Apoptosis Market Regional Outlook 2012-2022($ Million)
4.1. North America
4.2. Europe
4.3. Asia Pacific
4.4. Middle East & Africa
4.5. Latin America

5. Company profiles
5.1. Abbott Laboratories
5.2. Aegera therapeutics Inc
5.3. Amgen Inc
5.4. Apicept Corporation
5.5. Bioniche Life Sciences Inc.
5.6. Celgene Corporation
5.7. Chromo Therapeutics Limited
5.8. EntreMed Inc
5.9. Exelixes Inc
5.10. Genta Inc.
5.11. Infinity Pharmaceuticals Inc.
5.12. Novartis Limited
5.13. Pfizer Inc
5.14. Xigen SA
5.15. Zentaris GmbH